HomeInsights52 Week Low Stocks

Aspira Pathlab & Diagnostics Ltd 52 Week Low

Aspira Pathlab & Diagnostics Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.2 K

stocks traded

Last Updated time: 05 Nov 10:15 AM

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

YEARLOW

25

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Aspira Pathlab & Diagnostics Ltd is ₹ 25 as of 04 Nov 24.

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 202455.66
01 Nov 202455.03
31 Oct 202453
30 Oct 202452.45
29 Oct 202449.96
28 Oct 202450.14
25 Oct 202449.18
24 Oct 202450.02
23 Oct 202452.44
22 Oct 202450.95

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Aspira Pathlab & Diagnostics Ltd News Hub

News

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

30 Oct 202416:55

News

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the compan...

Read more

28 Aug 202412:02

News

Aspira Pathlab & Diagnostics to announce Quarterly Result

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

05 Aug 202414:32

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

21 May 202412:07

News

Aspira Pathlab & Diagnostics revises board meeting date

Aspira Pathlab & Diagnostics has revised the meeting of the Board of Directors which was s...

Read more

06 Feb 202412:39

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

02 Feb 202415:34

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Aspira Pathlab & Diagnostics Ltd

Why is it important to track the 52-week low of Aspira Pathlab & Diagnostics Ltd stocks?

Investors should monitor the 52-week low of Aspira Pathlab & Diagnostics Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Aspira Pathlab & Diagnostics Ltd stocks hitting a 52-week low?

Factors leading to Aspira Pathlab & Diagnostics Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Aspira Pathlab & Diagnostics Ltd stocks when they hit a 52-week low?

Buying Aspira Pathlab & Diagnostics Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Aspira Pathlab & Diagnostics Ltd stocks?

Investors should monitor the 52-week low of Aspira Pathlab & Diagnostics Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Aspira Pathlab & Diagnostics Ltd stock at their 52-week low?

An investor can analyze the reasons for the Aspira Pathlab & Diagnostics Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Aspira Pathlab & Diagnostics Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Aspira Pathlab & Diagnostics Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Aspira Pathlab & Diagnostics Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*